In the first half of 2022, Xiaoke pill held a share of more than 23 percent in the public healthcare market in China, ranked first among diabetes drugs. Meanwhile, Yiling Pharmaceutical's Jinlida granule remained an important diabetes drug.
Market share of leading diabetes drugs in public healthcare market in China in first half of 2022
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Yiling Pharmaceutical. (April 26, 2023). Market share of leading diabetes drugs in public healthcare market in China in first half of 2022 [Graph]. In Statista. Retrieved December 26, 2024, from https://www.statista.com/statistics/1392640/china-market-share-of-major-diabetes-drugs-in-public-healthcare-market/?campaign=BranchenID-412&utm_souce=Blog
Yiling Pharmaceutical. "Market share of leading diabetes drugs in public healthcare market in China in first half of 2022." Chart. April 26, 2023. Statista. Accessed December 26, 2024. https://www.statista.com/statistics/1392640/china-market-share-of-major-diabetes-drugs-in-public-healthcare-market/?campaign=BranchenID-412&utm_souce=Blog
Yiling Pharmaceutical. (2023). Market share of leading diabetes drugs in public healthcare market in China in first half of 2022. Statista. Statista Inc.. Accessed: December 26, 2024. https://www.statista.com/statistics/1392640/china-market-share-of-major-diabetes-drugs-in-public-healthcare-market/?campaign=BranchenID-412&utm_souce=Blog
Yiling Pharmaceutical. "Market Share of Leading Diabetes Drugs in Public Healthcare Market in China in First Half of 2022." Statista, Statista Inc., 26 Apr 2023, https://www.statista.com/statistics/1392640/china-market-share-of-major-diabetes-drugs-in-public-healthcare-market/?campaign=BranchenID-412&utm_souce=Blog
Yiling Pharmaceutical, Market share of leading diabetes drugs in public healthcare market in China in first half of 2022 Statista, https://www.statista.com/statistics/1392640/china-market-share-of-major-diabetes-drugs-in-public-healthcare-market/?campaign=BranchenID-412&utm_souce=Blog (last visited December 26, 2024)
Market share of leading diabetes drugs in public healthcare market in China in first half of 2022 [Graph], Yiling Pharmaceutical, April 26, 2023. [Online]. Available: https://www.statista.com/statistics/1392640/china-market-share-of-major-diabetes-drugs-in-public-healthcare-market/?campaign=BranchenID-412&utm_souce=Blog
